Walgreens Boots Alliance, Inc. (W8A.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 01:00PM CEST. Market open.
| Previous close | 16.08 |
| Open | 16.27 |
| Bid | 16.53 x 30000 |
| Ask | 16.62 x 30000 |
| Day's range | 16.27 - 16.42 |
| 52-week range | 16.08 - 30.44 |
| Volume | |
| Avg. volume | 866 |
| Market cap | 14.282B |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.53 |
| Earnings date | 25 Jun 2024 - 01 Jul 2024 |
| Forward dividend & yield | 0.93 (5.81%) |
| Ex-dividend date | 20 May 2024 |
| 1y target est | 52.09 |
ZacksWalgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $17.53, indicating a +1.1% shift from the previous trading day.
Yahoo FinanceWalgreens partners with Boehringer Ingelheim for clinical trials
Walgreens is ramping up its clinical trial offerings with Big Pharma players.
Business WireWalgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
DEERFIELD, Ill. & RIDGEFIELD, Conn., May 02, 2024--Walgreens and Boehringer Ingelheim today announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable. This collaboration will offer people an opportunity to learn about and potentially participate in an important Phase III clinical trial within the familiar and accessible environment of Walgreens pharmacies, reflecting a shared vision to expand access to healthcare and r
© 2024 Yahoo. All rights reserved.